PDS Biotechnology Corporation
Price
FilingsNewest: 8-K, Other eventsSep 22 →InsidersNo open-market buys or sales.→HoldersVanguard 3.0%Focus Partners Wealth 1.1%Quantinno 1.1%→Financing →PeersClosest companies: BCAB, IMUX, MBRX→
From the filings
Figures
- Net income
- −$33.7Mlast 12 months
- Operating cash flow
- −$23.1Mlast 12 months
- Cash and equivalents
- $5.6Mat the last balance sheet
- Shares outstanding
- 55.9M shareson issue